Review of Efficacy and Safety of Duloxetine 40 to 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain

We summarize efficacy and safety findings from 4 double-blind, placebo-controlled, 12-week studies and 1 open-label, uncontrolled, 34-week maintenance-of-effect (MOE) study that examine duloxetine 40 and 60 mg once daily (QD) in patients with diabetic peripheral neuropathic pain (DPNP). In all place...

Descripción completa

Detalles Bibliográficos
Autores principales: Skljarevski, Vladimir, Frakes, Elijah P., Sagman, Doron, Lipsius, Sarah, Heinloth, Alexandra N., Dueñas Tentori, Héctor J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437646/
https://www.ncbi.nlm.nih.gov/pubmed/22973509
http://dx.doi.org/10.1155/2012/898347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437646/
https://www.ncbi.nlm.nih.gov/pubmed/22973509
http://dx.doi.org/10.1155/2012/898347

Ejemplares similares